Objective: In this study, we aimed to discuss the effect of Curcumin and/or Irbesartan on diabetic complications in induced diabetic rats. Material and Methods: Diabetic rats induced by intraperitoneal injection of 45mg/kg dose of Streptozotocin (STZ) in adult rats. Rats were divided into six groups of ten rats on each. Serum glucose, creatinine, and urea were estimated using a colorimetric method. Serum insulin and serum and kidney homogenate interleukin 6 (IL6) were measured using ELISA technique. While paraffin embedded kidney and pancreas specimens were performed for histopathological examination. While Homeostasis model assessment of insulin resistance (HOMA-IR)was calculated. Results: curcumin and/or irbesartan reduce the degradation of kidneys and pancreatic tissues as indicated in both histopathology and tissue IL-6. They improve the weight loss and insulin resistance. Also, they lower circulating level of IL-6, serum creatinine, and urea. Diabetic rats received the medications show significantly better insulin and glucose levels as compared to STZ group. Conclusion: Chronic administration of curcumin and/or irbesartan for diabetic rats decreased serum glucose and HOMA-IR and lowered the increased serum levels of pro-inflammatory cytokines. Using such combination could be beneficial in diabetic managements especially if diabetes accompanied with hypertension.
No takes yet. Share an insight, caveat, or question.
Nassar et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: